Acute myocardial infarction: Are there missed opportunities for reperfusion?

Coronary Artery Disease

Volumn 9, Issue 11, 1998, Pages 753-758

  El Gaylani, Nadia ^d   Weston, Clive F ^d   Griffith, Kathryn ^a   Wong, Peter S C ^b   Norris, Robin M ^b   Penny, William J ^c  

^a YORK HOSPITAL   (United Kingdom)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^d University Hospital of Wales ^*

Author keywords

Acute myocardial infarction; Primary PTCA; Thrombolytic therapy

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT CONTRAINDICATION; UNITED KINGDOM;

EID: 0032409559     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199809110-00008     Document Type: Article

References (39)

1. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1:397-401.
2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17\th187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; ii:349-360.
3. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343:311-322.
4. The Reperfusion Therapy Consensus Group. Selection of reperfusion therapy for individual patients with evolving myocardial infarction. Eur Heart J 1997; 18:1371-1381.
5. Zijlstra F, DeBoer MJ, Hoorntje JCA, Reiffers S, Reber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328:680-684.
6. Grines CL, Browne CR, Marco J, Rothbaum D. Stone GW, O'Keefe J, et al. A comparison of primary angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328:673-679.
7. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? Circulation 1995; 91:476-485.
8. The Global Use of Strategies To Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) angioplasty substudy investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336:1621-1628.
9. Simoons ML, Vos J, Tijssen JGP, Vermeer F, Verheught F, Krauss XH, et al. Long term benefit of early thrombolytic therapy in patients with acute myocardial infarction: a 5 year follow-up of a trial conducted by the interuniversity cardiology institute of the Netherlands. J Am Coll Cardiol 1989; 14:1609-1615.
10. Serruys PW, Simoons ML, Suryapranata H, Vermeer F, Wijns W, van den Brand M, et al. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol 1986; 7:729-742.
11. Van de Werf F, Arnold AER, for the European Co-operative Study Group for Recombinant Tissue Plasminogen Activator. Intravenous tissue plasminogen activator and size of infarct left ventricular function and survival in acute myocardial infarction. BMJ 1988; 297:1374-1379.
12. Granger CB, White HD, Bates ER, Ohman EM, Califf RM. A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction. Am J Cardiol 1994; 74:1220-1228.
13. Boersma E, Maas ACP, Deckers JW, Simoons ML Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996; 348:771-775.
14. Ketley D, Woods KL, for the European Secondary Prevention Study Group. Selection factors for the use of thrombolytic treatment in acute myocardial infarction: a population based study of current practice in the United Kingdom. Br Heart J 1995; 74:224-228.
15. Norris RM, Roy S, Dixon GF. What proportion of patients with acute myocardial infarction should receive thrombolytic therapy? [abstract], Br Heart J 1994; 71:40.
16. European Secondary Prevention Study Group. Translation of clinical trials into practice: a European population based study of the use of thrombolysis for acute myocardial infarction. Lancet 1996; 347:1203-1207.
17. The UK Heart Attack Study Collaborative Group. Effect of time from onset to coming under care on fatality of patients with acute myocardial infarction: effect of resuscitation and thrombolytic treatment. Heart 1998: 80:114-120.
18. Cragg DR, Friedman HZ, Bonema JD, Jayesimi IA, Ramos RG, Timmis GC, et al. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. Ann Intern Med 1991; 115:173-177.
19. Brodie BR. Primary angioplasty in a community hospital in the USA. Br Heart J 1995; 73:411-412.
20. O'Keefe JH Jr. Bailey WL, Rutherford BD, Hartzler GO. Primary angioplasty for acute myocardial infarction in 1,000 consecutive patients: results in an unselected population and high-risk subgroups. Am J Cardiol 1993; 72:107G-115G.
21. Himbert D, Juliard JM, Steg PG, Badaoui G, Baleynaud S, Le Gudulec D, et al. Primary coronary angioplasty for acute myocardial infarction with contraindication to thrombolysis. Am J Cardiol 1993; 71:377-381.
22. Norris RM, on behalf of the UK Heart Attack Study Collaborative Group Fatality outside hospital from acute coronary events in three British health districts 1994-95. BMJ 1998; 316:1065-1070.
23. The UK Heart Attack Study Collaborative Group. The falling mortality from coronary heart disease: a clinico-pathological perspective. Heart 1998; 80:121-126.
24. Van Campen LCMC, Van Leeuwen GR, Verheugt WA. Safety and efficacy of thrombolysis for acute myocardial infarction in patients with prolonged out-of-hospital cardiopulmonary resuscitation. Am J Cardiol 1994; 73:953-955.
25. Tenaglia AN, Califf RM, Candela RJ, Kereaikes DM, Berrios E, Young SY, et al. Thrombolytic therapy in patients requiring cardiopulmonary resuscitation. Am J Cardiol 1991; 68:1015-1019.
26. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Acute myocardial infarction: pre-hospital and in-hospital management. Eur Heart J 1996; 17:43-63.
27. Barbash GI, White HD, Modan M, Van de Werf F, for the investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. J Am Coll Cardiol 1993: 22:707-713.
28. EMERAS (Estudio Multicentico Estreptoquinqsa Republicas de America del Sur) Collaborative Group. Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet 1993; 342:767-772.
29. Lange RA, Hillis LD. Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? Thrombolysis - the preferred treatment. N Engl J Med 1996; 335:1311-1312.
30. Weaver WD, Litwin PE, Martin JS, Hallstrom A. Use of thrombolytic therapy: how much impact have we made? J Am Coll Cardiol 1994; 24:1242-1248.
31. Every NR, Larson EB, Litwin PE, Maynard C, Fihn SD, Eisenberg MS, et al. The association between on-site cardiac cathetensation facilities and the use of coronary angiography after acute myocardial infarction. N Engl J Med 1993; 329:546-551.
32. Thompson PL, Parson RW, Jamrozik K, Hockey RL, Hobbs MS, Broadhurst RJ. Changing patterns of medical treatment of acute myocardial infarction. Observations from the Perth Monica Project 1984-1990. Med J Australia 1992; 157:87-92.
33. Venturini F, Romero M, Tognoni G. Acute myocardial infarction treatments in 58 Italian hospitals: a drug utilisation survey. Ann Pharmacother 1995; 29:1100-1105.
34. Rustige J, Schiele R, Burczyk U, Koch A, Gottwik M, Neuhaus KL, et al. The 60 minutes myocardial infarction project. Treatment and clinical outcome of patients with acute myocardial infarction in Germany. Eur Heart J 1997; 18:1438-1446.
35. The GUSTO angiographic investigators. The effect of tissue plasminogen activator, streptokinase or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993; 329:1615-1622.
36. Ellis SG, da Silva ER, Heyndrickx G, Talley D, Cernigliano C, Steg G, et al. Randomised comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 1994; 90:2280-2284.
37. The CORAMI study group. Outcome of attempted rescue coronary angioplasty after failed thrombolysis for acute myocardial infarction. Am J Cardiol 1994; 74:172-174.
38. Vogt A, Von Essen R, Tebbe U, Feuerer W, Appel K-F, Neuhaus K-L. Impact of early perfusion status of the infarct-related artery on short term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. J Am Coll Cardiol 1993; 21:1391-1395.
39. Moliterno DJ, Lange RA, Willard JE, Boehrer JD, Hillis LD. Does restoration of antegrade flow in the infarct-related coronary artery days to weeks after myocardial infarction improve long-term survival? Coronary Artery Dis 1993; 3:299-304.